OK, that helps. Maybe it's a worst case scenario. In the meantime we have melanoma study results to watch for. Pre-clinical results there were pretty interesting in my view. We may have new owners well before the fx and cx trials ever come to completion, if they have obviously good results in those M. combo trials, (long shot, I know).
Have to think about the situation with my warrants. It seems like I have some time to decide what to do, especially with fx study results and melanoma results due prior to expiration. Plus, maybe there'll be some interim reports on the cx study (?)
If this keeps dropping, and I can afford it, I may buy a bit more but lately all of my free cash is going into my other favorite.
–D
News 
Market Data 
Discover 
